Compare

Axon Enterprise vs TransDigm

MonkScore ranges and fundamentals, side by side

Key facts

Axon Enterprise and TransDigm: key facts

  • In fiscal 2025, Axon Enterprise, Inc. reported revenue of $2.8B and net income of $124.9M.
  • In fiscal 2025, TransDigm Group Incorporated reported revenue of $8.8B and net income of $2.1B.
  • Axon Enterprise, Inc.'s revenue grew 33.9% a year from fiscal 2021 to fiscal 2025.
  • TransDigm Group Incorporated's revenue grew 16.5% a year from fiscal 2021 to fiscal 2025.
  • Axon Enterprise, Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • TransDigm Group Incorporated's free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • In the twelve months to 30 June 2026, Axon Enterprise, Inc. reported revenue of $3.2B and net income of $199.6M.
  • In the twelve months to 27 June 2026, TransDigm Group Incorporated reported revenue of $10.0B and net income of $2.1B.

Side by side

Axon Enterprise and TransDigm, side by side

Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.

FigureAxon Enterprise, Inc.NASDAQ:AXONTransDigm Group IncorporatedNYSE:TDG
MonkScore
MonkScore range70–80as of October 202660–70as of October 2026
Sector rank279 of 1409 in Industrials442 of 1409 in Industrials
How this score is madeDisclaimer
Profile
SectorIndustrialsIndustrials
IndustryAerospace & DefenseAerospace & Defense
Latest fiscal year
Revenue$2.8BFY 2025$8.8BFY 2025
Net income$124.9MFY 2025$2.1BFY 2025
Free cash flow$75.1MFY 2025$1.8BFY 2025
Operating cash flow$211.3MFY 2025$2.0BFY 2025
Total debt$1.9BFY 2025$30.0BFY 2025
Cash$1.2BFY 2025$2.8BFY 2025
Last 12 months
Revenue$3.2Bto 30 June 2026$10.0Bto 27 June 2026
Net income$199.6Mto 30 June 2026$2.1Bto 27 June 2026
Free cash flow$133.2Mto 30 June 2026$1.9Bto 27 June 2026
Operating cash flow$265.8Mto 30 June 2026$2.2Bto 27 June 2026
Total debt$1.8Bto 30 June 2026$33.5Bto 27 June 2026
Cash$597.7Mto 30 June 2026$2.8Bto 27 June 2026

MonkStreet provides research, not investment advice.